ANALYSIS: GPOs Helped Increase Domestic Manufacturing Capacity, Protected Hospitals and Patients from Thousands of Fraudulent Sellers, and Helped Identify and Bring New Suppliers to Market to Avert Supply and Drug Shortages During COVID-19
HSCA Releases Issue Brief Detailing Learnings and Best Practices from Industry COVID-19 Response.
Click here to read the full comments.
Related Posts
HSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
June 29, 2020
Dear Chairman Alexander and Ranking Member Murray: On behalf of the...
HSCA RELEASES HEALTHCARE CYBERSECURITY KEY CONSIDERATIONS TO HELP PROTECT PATIENT HEALTH, SAFETY, AND PRIVACY
December 21, 2021
Washington, DC (December 21, 2021) – The Healthcare Supply Chain Association...
Joint Letter of Support for the MEDS Act
November 5, 2019
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
April 1, 2022
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...